Glycosylation defining cancer cell motility and invasiveness
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Glycoconjugate Journal
- Vol. 20 (1) , 71-78
- https://doi.org/10.1023/b:glyc.0000018019.22070.7d
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Tetraspanin CD9 Is a “Proteolipid,” and Its Interaction with α3 Integrin in Microdomain Is Promoted by GM3 Ganglioside, Leading to Inhibition of Laminin-5-dependent Cell MotilityPublished by Elsevier ,2002
- Glycosylation Affects Translocation of Integrin, Src, and Caveolin into or out of GEMBiochemical and Biophysical Research Communications, 2000
- Separation of “Glycosphingolipid Signaling Domain” from Caveolin-containing Membrane Fraction in Mouse Melanoma B16 Cells and Its Role in Cell Adhesion Coupled with SignalingJournal of Biological Chemistry, 1998
- A Novel Link between Integrins, Transmembrane-4 Superfamily Proteins (CD63 and CD81), and Phosphatidylinositol 4-KinasePublished by Elsevier ,1997
- CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA‐DR and VLA integrinsEuropean Journal of Immunology, 1996
- Preparation of rediolabeled gangliosidesGlycobiology, 1996
- KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2Science, 1995
- Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility.The Journal of Experimental Medicine, 1991
- Human lung adenocarcinoma cell lines with different lung colonization potential (LCP), and a correlation between expression of sialosyl dimeric Lex (defined by MAb FH6) and LCPClinical & Experimental Metastasis, 1991
- Glycoconjugate expression during embryogenesis and its biological significanceBioEssays, 1990